Stepwise direct reprogramming of adult human dermal fibroblasts into tendon-like cells via transcription factor optimization and 3D culture

In the world of pediatric surgery, repairing a hole in the diaphragm—the muscle that separates the chest from the belly and helps us breathe—is a high-stakes challenge. When the defect is too large to simply stitch closed, surgeons often rely on synthetic patches made of materials like expanded polytetrafluoroethylene. While these artificial sheets can hold the body together in the short term, they have a critical flaw: they are dead matter. They cannot grow, they do not adapt to a child's expanding body, and they carry risks of infection or calcification over time. The ultimate goal for doctors is to replace these static patches with living tissue that a child's body can accept and that will grow alongside them. To achieve this, scientists are exploring a method called direct reprogramming. This process involves taking a mature, specialized cell from one part of the body and giving it a new set of instructions to transform it into a different type of cell entirely, bypassing the need to create stem cells first. The question researchers have been asking is whether they can turn a common skin cell into a tendon cell, a crucial component of the diaphragm, to build a living, growing repair.

A team of researchers at Kyoto Prefectural University of Medicine set out to answer this question by attempting to turn adult human skin cells into tendon-like cells. They started with adult human dermal fibroblasts, which are the workhorse cells found in the skin that produce collagen and maintain tissue structure. These cells are abundant and easy to obtain from a patient, making them an ideal starting point. The scientists introduced a specific group of genes into these skin cells using a harmless virus. These genes act as master switches, or transcription factors, that tell the cell which proteins to make and what job to perform. Initially, the team tested a combination of six different factors, including some known to drive tendon development and others used to make cells more flexible and ready to change. They wanted to see if this cocktail could force the skin cells to forget their original identity and adopt the characteristics of a tenoblast, a cell that builds and maintains tendons.

The experiment showed that the six-factor combination worked. The skin cells began to produce high levels of tenomodulin and thrombospondin-4, two proteins that serve as clear markers for tendon cells. When the researchers looked at the cells under a microscope, they saw a physical transformation. The original skin cells were short and spindle-shaped, but the reprogrammed cells stretched out, becoming long and thin, resembling the fibers of a real tendon. To ensure these new cells were stable, the team placed them under the skin of mice. Within a week, the cells had survived and formed small clusters in the graft, proving that the reprogrammed cells could persist in a living body without immediately dying or causing inflammation. This initial success confirmed that the concept was viable, but the team knew that using six factors was more complex than necessary. They wanted to find the simplest, most efficient recipe to achieve the same result.

Through a process of elimination, the researchers tested different combinations of the factors to find the minimal set required. They discovered that four factors were sufficient: SCX, MKX, OCT3/4, and MYCL. The study revealed that each of these factors played a distinct role in the transformation. One factor, OCT3/4, was essential for turning on the gene for tenomodulin, while another, SCX, was the primary driver for the production of thrombospondin-4. The other two factors helped the process run smoothly and efficiently. This finding was significant because it simplified the procedure, reducing the number of genetic instructions needed to create the desired cell type. The researchers named these successfully converted cells "directly converted tenoblasts." They confirmed that these cells looked like tendon cells and produced the correct proteins, even though they started as skin cells.

The team then investigated whether the environment in which the cells grew could improve their development. Cells grown in a flat dish, known as two-dimensional culture, showed good results, but the researchers wondered if a more natural, three-dimensional environment would help. They embedded some of the converted cells in a gel made of collagen, a material that mimics the natural scaffolding of the body. They found that moving the cells into this three-dimensional gel after they had already spent some time in the flat dish further boosted the expression of tendon markers. Specifically, the cells that were transferred to the gel later in the process showed the highest levels of the key proteins. This suggested that the cells needed to establish their new identity in a simple environment first before the complex, three-dimensional structure could help them mature further.

While the results were promising, the researchers were careful to note the limits of their current work. They had successfully created cells that looked and acted like tendon cells in a dish and survived for a short time in mice, but they had not yet tested if these cells could withstand the physical stress of a real tendon or if they could integrate fully into a growing body over the long term. The study did not measure the strength of the new tissue or how well it would function in a human patient. However, the work provided a clear, step-by-step path forward. By identifying the specific four factors needed and the best way to culture the cells, the team has laid a foundation for creating patient-specific tendon tissue. This approach could eventually lead to the development of living, growing patches for children with diaphragmatic hernias, offering a solution that adapts and grows with the patient rather than remaining a static, foreign object.